The Baiyunshan (600332.SH) branch received the registration certificate for the Cefaclor sustained-release tablets () drug.

Wisdom Financial News APP News, Baiyunshan (600332.SH) announced that recently, Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd., a subsidiary of the company, Baiyunshan Pharmaceutical General Factory, received the "Drug Registration Certificate" issued by the National Medical Products Administration for Cefaclor Sustained-Release Tablets ().